The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
1023502614 10235026 14 F 20130929 20151227 20140613 20151231 EXP PHHY2011CA80563 NOVARTIS 77.14 YR M Y 0.00000 20160101 MD CA CA

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
1023502614 10235026 1 PS SANDOSTATIN LAR DEPOT OCTREOTIDE ACETATE 1 Intramuscular 30 MG, QMO (EVERY 4 WEEKS) 21008 30 MG /month
1023502614 10235026 2 SS SANDOSTATIN OCTREOTIDE ACETATE 1 Subcutaneous UNKNOWN TEST DOSE 0
1023502614 10235026 3 C ALLOPURINOL. ALLOPURINOL 1 Subcutaneous 0
1023502614 10235026 4 C CRESTOR ROSUVASTATIN CALCIUM 1 Unknown 0
1023502614 10235026 5 C ATACAND CANDESARTAN CILEXETIL 1 Unknown 0

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
1023502614 10235026 1 Pancreatic neuroendocrine tumour
1023502614 10235026 2 Pancreatic neuroendocrine tumour
1023502614 10235026 3 Product used for unknown indication
1023502614 10235026 4 Product used for unknown indication
1023502614 10235026 5 Product used for unknown indication

Outcome of event

Event ID CASEID OUTC COD
1023502614 10235026 DE
1023502614 10235026 HO

Reactions reported

Event ID CASEID DRUG REC ACT PT
1023502614 10235026 Anorectal discomfort
1023502614 10235026 Arthralgia
1023502614 10235026 Back pain
1023502614 10235026 Blood glucose increased
1023502614 10235026 Blood pressure increased
1023502614 10235026 Circulatory collapse
1023502614 10235026 Constipation
1023502614 10235026 Contusion
1023502614 10235026 Death
1023502614 10235026 Diarrhoea
1023502614 10235026 Epistaxis
1023502614 10235026 Fall
1023502614 10235026 Gait disturbance
1023502614 10235026 Headache
1023502614 10235026 Hip fracture
1023502614 10235026 Hypotension
1023502614 10235026 Injury
1023502614 10235026 Muscle strain
1023502614 10235026 Pain
1023502614 10235026 Pain in extremity
1023502614 10235026 Syncope

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
1023502614 10235026 1 20110117 0
1023502614 10235026 2 20110106 20110106 0